VIATRIS INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
VIATRIS INC. (VTRS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 19.90 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- VIATRIS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 19.90M shares, a 27.90% decline year-over-year.
- VIATRIS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 11.20M shares, a 58.97% decline year-over-year.
- VIATRIS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 12.90M shares, a 41.76% increase year-over-year.
- VIATRIS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 27.60M shares, a 18.97% increase year-over-year.
- VIATRIS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 28.10M shares, a 41.21% increase from fiscal 2024.
- VIATRIS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 19.90M shares, a 21.34% increase from fiscal 2023.
- VIATRIS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 16.40M shares, a 38.98% increase from fiscal 2022.
- VIATRIS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 11.80M shares, a 7.09% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 19.90M shares 10-Q · filed 2026-08-06 | 11.00M shares 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | 11.20M shares 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 28.10M shares 10-K · filed 2026-02-26 | |||
| 2025-09-30 | 12.90M shares 10-Q · filed 2025-11-06 | 22.60M shares 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | 27.60M shares 10-Q · filed 2026-08-06 | 27.40M shares 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | 27.30M shares 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | 19.90M shares 10-K · filed 2026-02-26 | |||
| 2024-09-30 | 9.10M shares 10-Q · filed 2025-11-06 | 20.50M shares 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | 23.20M shares 10-Q · filed 2025-08-07 | 22.70M shares 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | 7.90M shares 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | 16.40M shares 10-K · filed 2026-02-26 | |||
| 2023-09-30 | 12.20M shares 10-Q · filed 2024-11-07 | 16.80M shares 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | 24.20M shares 10-Q · filed 2024-08-08 | 19.00M shares 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | 13.90M shares 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | 11.80M shares 10-K · filed 2025-02-27 | |||
| 2022-09-30 | 14.70M shares 10-Q · filed 2023-11-08 | 13.30M shares 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | 9.80M shares 10-Q · filed 2023-08-07 | 12.60M shares 10-Q · filed 2023-08-07 | ||
| 2022-03-31 | 15.50M shares 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | 12.70M shares 10-K · filed 2024-02-28 | |||
| 2021-09-30 | 11.40M shares 10-Q · filed 2022-11-07 | 10.80M shares 10-Q · filed 2022-11-07 | ||
| 2021-06-30 | 10.00M shares 10-Q · filed 2022-08-08 | 10.50M shares 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | 10.90M shares 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | 10.30M shares 10-K · filed 2023-02-27 | |||
| 2020-09-30 | 8.80M shares 10-Q · filed 2021-11-08 | 9.80M shares 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | 11.10M shares 10-Q · filed 2021-08-09 | 10.40M shares 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | 9.60M shares 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | 9.10M shares 10-K · filed 2022-02-28 | |||
| 2018-12-31 | 8.90M shares 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |